Newsroom | 40134 results
Sorted by: Latest
-
Sutter Health Expands Use of Wearable Ultrasound Tech Across Additional Bay Area Hospitals to Advance Sepsis Care
LOS ANGELES--(BUSINESS WIRE)--Sutter Health is expanding the use of FloPatch, the first wireless, wearable Doppler ultrasound device, across three additional Northern California hospitals: Sutter Solano Medical Center in Vallejo, Sutter’s Mills-Peninsula Medical Center in Burlingame and the Berkeley campus of Sutter’s Alta Bates Summit Medical Center, as part of its ongoing effort to enhance personalized intravenous (IV) fluid management for patients with sepsis and other life-threatening condi...
-
WHOOP to Transform Boston Marathon Weekend into a Citywide Celebration of Performance, Recovery, and Community
BOSTON--(BUSINESS WIRE)--WHOOP, the human performance company, is bringing its hometown energy to the 2026 Boston Marathon with a citywide activation designed to celebrate runners, engage the Boston community, and redefine how athletes approach performance and recovery. Founded at the Harvard Innovation Lab in 2012 and still headquartered in Boston’s Kenmore Square, WHOOP is uniquely positioned to shape how athletes and spectators experience one of the most iconic events in sport. Timed to a de...
-
ValGenesis Launches the Next Generation of VAL™, Bringing Governed AI to the Validation Lifecycle
SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis to debut the next generation of VAL™ (ValGenesis AI) at INTERPHEX 2026. Visit booth 3552 for demos and pilot program information....
-
Atia Vision Announces Durable 36-Month Results from First-in-Human Study of their Dynamic Shape-Changing OmniVu Intraocular Lens System
CAMPBELL, Calif.--(BUSINESS WIRE)--Atia Vision Announces Durable 36-Month Results from First-in-Human Study of their Dynamic Shape-Changing OmniVu Intraocular Lens System...
-
Calyxo Secures $40 Million Series F Financing as CVAC System Surpasses 40,000 Patients Treated for Kidney Stone Removal
PLEASANTON, Calif.--(BUSINESS WIRE)--Calyxo, Inc., a medical device company redefining kidney stone treatment, today announced the closing of a $40 million Series F financing round, led by Ally Bridge Group and Janus Henderson Investors, with continued support from Questa Capital, Avidity Partners, and CRG. The financing follows a key company milestone; 40,000 patients treated with the CVAC System. Adoption of Calyxo’s all-in-one aspiration-based stone removal system reflects increasing clinici...
-
AtriCure to Announce First Quarter 2026 Financial Results
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026. AtriCure will host an audio webcast at 4:30 p.m. Eastern Time on Tuesday, May 5, 2026, to discuss its first quarter financial results. Those interested in listening to th...
-
Immertec Expands Global Infrastructure to Power Scalable, Localized Training for Medical Device Companies
LEWISVILLE, Texas--(BUSINESS WIRE)--Immertec, a healthcare training and awareness technology company focused on expanding access to procedural education, today announced a significant expansion of its global infrastructure. The enhanced model enables medical device companies to deliver live and on-demand surgical training for internal teams and physician education programs worldwide—reducing traditional barriers to operating room access. As medical device companies continue to invest in global...
-
Novigenix AI to Present Clinical Data at AACR 2026 Linking Immuno-Pharmacodynamics to Radioligand Therapy Response
EPALINGES, Switzerland--(BUSINESS WIRE)--Novigenix AI, a leader in AI-driven healthcare solutions, today announced the presentation of new data at the American Association for Cancer Research (AACR) 2026 Annual Meeting demonstrating, for the first time in a human clinical setting, the dynamic role of the immune system in response to radioligand therapy in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NET).1 The study, conducted in collaboration with RadioMedix, Inc....
-
4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program
NEWTON, Mass.--(BUSINESS WIRE)--4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program...
-
SSRP Institute Welcomes Medivive as New Trusted Partner
WILLOUGHBY, Ohio--(BUSINESS WIRE)--The SSRP Institute is pleased to announce that Medivive has joined its Trusted Partner Network following nomination and internal vetting aligned with SSRP’s mission of advancing science-first, education-driven clinical collaboration. Medivive offers an advanced approach to NAD⁺ therapy designed to support cellular energetics through sterile, clinician-prescribed formulations produced under current Good Manufacturing Practices (cGMP) and dispensed by licensed p...